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ABSTRACT 
The aggressive nature of estrogen receptor (ER)-negative breast cancer subtype obligates for 
innovative targeted therapies. The present study aimed to investigate the phytoconstituents 
and specific anticancer activities of Rheum emodi rhizome, a known food source used locally 
to treat various ailments. Petroleum ether extracts (hot [PHR] and cold [PCR]) of R. emodi, 
exhibited significant free radical scavenging potentials through DPPH and reducing power 
assays, rendering them as good sources of antioxidants. The extracts, PHR and PCR had 
shown significant (P < 0.05) cancer-cell-specific cytotoxicity in the assayed cells (MDA-MB-
231 [breast carcinoma] and WRL-68 [non-tumoral]) at 100 μg/ml, and 50 and 100 μg/ml con-
centrations respectively. Extracts also induced fervent apoptosis in ER-negative cells (MDA-
MB-231) compared to ER-positive subtype (MCF-7), and found to involve CPP32/caspase-3 
in its apoptosis induction mechanism. Moreover, extracts had an inevitable potential to inhibit 
the migration of metastatic breast cancer cells (MDA-MB-231) in vitro. Further, the active 
principles of extracts were identified through HPLC and GC-MS analysis to reveal major pol-
yphenolics, 4,7-Dimethyl-(octahydro)indolo[4,3-fg]quinolin-10-one, 5-Oxo-isolongifolene, 
Valencene-2, and other quinone, quinoline and anthraquinone derivatives. The extracts are 
thus good candidates to target malignant ER-negative breast cancer, and the identified phyto-
constituents could be eluted in further exploratory studies for use in dietary-based anti-breast 
cancer therapies. 
 
Keywords: Cancer-specific cytotoxicity, ER-negative breast cancer, caspase-3,  
anti-metastasis, HPLC, GC-MS 
 
 
INTRODUCTION 
Cancer is one of the largest causes of 
mortality in human race. Of which, breast 
cancer is the most common in women, and 
standing second as leading causes of death 
(CDC, 2012). Regardless of advances in 
treatment, resistance development to cancer 
drugs is a major hindrance in treating ma-
lignant cancers. The nature of heterogeneity 
and the ability to metastasize necessitates 
the need for innovative breast cancer thera-
pies. Predominantly, the modern therapies 
are expected to explicitly target on specific 
genes or their proteins in comparison to 
conventional cytotoxic chemotherapy 
(Rochefort et al., 2003). The targeted thera-
pies are also anticipated to possess higher 
efficiency with lesser non-specific toxicity 
in patients (Gibbs, 2000). Being the first 
successful hormonal therapy in breast can-
cer, anti-estrogen therapy is limited to ER-
positive subtype (Hsieh et al., 2011). Nev-
ertheless, ER-negative breast cancers are 
reported to be the most aggressive subtype 
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(Putti et al., 2005), requiring the urgent at-
tention for additional targeted therapies 
(Rochefort et al., 2003; Hsieh et al., 2011). 
In most of the cancer types, the course of 
carcinogenesis is a multi-step progress that 
includes initiation, promotion, progression 
and metastasis of tumor. 
Copious phytochemicals are being re-
ported to arrest or inhibit various stages of 
carcinogenesis in breast cancer. The targets 
of such chemopreventive agents vary sys-
tematically as, prevention of cancer initia-
tion through DNA repair, free-radical scav-
enging, detoxification and blocking carcin-
ogen metabolism, treating promotion and 
progression by inhibition of cell prolifera-
tion, migration and angiogenesis, apoptosis 
induction, and cancer cell-differentiation 
and cell death (Shu et al., 2010). Of these, 
the therapy involving cell cycle arrest 
and/or apoptosis induction is considered as 
one of the promising strategies for chemo-
prevention (Pan and Ho, 2008). Apoptosis 
induction is attained by both intrinsic (mi-
tochondrial) and extrinsic (death receptor) 
mechanisms. Conversely, both the path-
ways converge and progress through a 
common effector caspase; caspase-3, which 
results in immediate cell death through cel-
lular targets (Janicke et al., 1998). A potent 
chemopreventive agent also entails inhibi-
tion of cancer cell migration in advanced 
stages of malignancy (metastasis), reported 
to cause major mortality in cancer (Fidler, 
2003). Hence, targeting by an agent with 
caspase-3 activation specificity could be a 
successful strategy in treating breast cancer 
malignancy (Putt et al., 2006). 
Since decades, plant sources are being 
the promising candidates for their higher 
efficacies as chemopreventives. Obstinate 
evidences have been reported for an associ-
ation of regular consumption of plant prod-
ucts as dietary supplements and reduced 
risk of cancer, further, whose screening in 
vitro could provide imperative data for se-
lection of plant extracts with potential 
antineoplastic properties for exploratory 
studies (Luo et al., 2011; Sreelatha et al., 
2011). Rheum emodi Wall. ex Meissn. 
(Polygonacea) is one such well known 
Himalayan herb, which has beforehand re-
ports for its use in Ayurvedic and tradition-
al medicine systems to treat various ail-
ments (Singh et al., 2010), and was record-
ed as an important source of food for tribal 
and rural people of Kashmir (Kounsar et al., 
2011). The plant was previously showed to 
possess few well known therapeutic com-
pounds such as chrysophanol, physcion and 
emodin (Babu et al., 2003). R. emodi has 
also been previously reported for its antiox-
idant, cytotoxic and apoptotic properties 
(Babu et al., 2003; Rajkumar et al., 2010; 
2011). However, there is a lack of reports 
pertaining to the mechanism of action, and 
other phytoconstituents responsible for the 
stated bioactivities of these extracts. This 
created a scientific state of interest to ex-
plore the overseen components of R. emodi, 
which was the primary focus of this study, 
where the petroleum ether extracts of R. 
emodi have been scrutinized for their mode 
of action and their phytochemical constitu-
ents with promising and specific anticancer 
activities. 
 
MATERIALS AND METHODS 
Chemicals 
2,2-Diphenyl-1-picrylhydrazyl (DPPH), 
ascorbic acid, gallic acid, phenazine metho-
sulfate (PMS) (also known as N-methyl-
phenazonium methosulfate), L-15 (Leibo-
vitz) cell culture medium (with L-gluta-
mine) and MEM (minimal essential medi-
um) cell culture medium (with Earle’s salt, 
NEAA and L-glutamine) were purchased 
from Himedia Laboratories Pvt. Ltd. (In-
dia). XTT {2,3-bis(2-methoxy-4-nitro-5-
sulfophenyl)-5-[(phenylamino) carbonyl]-
2H-tetrazolium hydroxide} was obtained 
from Sigma Chemical Co. (St. Louis, MO, 
USA). Folin–Ciocalteau reagent was pro-
cured from Sisco Research Lab (India). 
Cellular DNA fragmentation ELISA (Cat. 
No. 11 585 045 001) to determine apoptosis 
was procured from Roche Diagnostics, 
Germany. Caspase-3/CPP32 Colorimetric 
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Assay Kit (Cat. No. K106-25) was procured 
from BioVision Incorporated, CA, USA. 
The remaining chemicals and solvents used 
were of standard analytical grade and 
HPLC grade, respectively.  
 
Plant material 
Rheum emodi rhizomes was collected 
from their natural habitat in the Garhwal 
Himalayas at Chamoli (30º 24’ N, 79º 
21’ E), Uttaranchal, India. The specimens 
collected were shade-dried, powdered and 
used for solvent extraction. A voucher spec-
imen was maintained at our laboratory for 
future reference (Accession no.: 
VIT/SBCBE/CCL/07/6/04; Dated: June 11, 
2007). 
 
Extraction 
Rhizome powder was extracted with pe-
troleum ether by two experimental 
schemes. Petroleum ether hot extract (PHR) 
of the rhizome powder was obtained using a 
Soxhlet apparatus [with the powder (g): 
solvent (ml) ratio of 1:6] and the petroleum 
ether cold extract (PCR) was obtained by 
the method of maceration at room tempera-
ture with the flask shaken at regular inter-
vals. Further, the two extracts were evapo-
rated to dryness at 40 ºC under reduced 
pressure [petroleum ether: 180 mbar in a 
rotary evaporator (Büchi, Switzerland)]. 
The samples were then stored in a vacuum 
desiccator at room temperature until further 
use. 
 
Estimation of antioxidant potentials 
Reducing power assay 
The reducing power of the extracts was 
analysed by its ability to reduce Fe+3– Fe+2 
according to the method described by Yild-
irim et al. (2001). The extracts (20, 40, 60, 
80 and 100 μg) were added with 2.5 mL of 
0.2 M phosphate buffer (pH 6.6; 1.79 % 
NaH2PO4 and 1.89 % Na2HPO4) and 2.5 
mL of 1% potassium ferricyanide. The mix-
ture was incubated at 50 ºC for 30 min, af-
ter which 2.5 ml of trichloroacetic acid 
(10 % solution) was added to the tubes and 
centrifuged at 3000 rpm for 10 min. The 
upper layer solution (2.5 ml) was taken and 
added with an equal volume of distilled wa-
ter and 0.5 mL of 0.1% ferric chloride. Ab-
sorbance was then read at 700 nm using 
Cary 50 UV-Vis spectrophotometer (Vari-
an, Inc., CA, USA). Increasing absorbance 
value of the reaction mixture indicates an 
increase in reducing power of the extracts. 
DPPH radical scavenging assay 
The DPPH• radical scavenging ability of 
the extracts was measured by the method of 
Blois (1958) with some modifications. Var-
ying concentrations (200, 400, 600, 800 and 
1000 µg) of extracts were taken in separate 
test tubes and made up to 0.5 ml using eth-
anol. DPPH● solution, 3ml (0.1 mM in eth-
anol), was added to all the tubes. The tube 
with ethanol and DPPH● solution alone was 
maintained as controls. The tubes were in-
cubated in the dark for 30 min and the ab-
sorbance was measured at 517 nm with eth-
anol as blank. The percentage radical scav-
enging (RS %) was calculated using the 
formula: 
RS % = [(Ac-At) / Ac]X 100 
where Ac and At are the absorbance of 
the control and treated samples respective-
ly. 
 
Cell lines and maintenance 
Cell lines used in this study MDA-MB-
231 (human breast carcinoma), MCF-7 
(human breast carcinoma) and WRL-68 
(normal human liver embryonic) were at-
tained from National Centre for Cell Sci-
ence (Pune, India). MDA-MB-231 cells 
were maintained in L-15 (Leibovitz’s) cul-
ture medium added with 10% serum in a 
humidified atmosphere at 37 ºC without 
CO2. Whereas, MCF-7 and WRL-68 cells 
were maintained in Minimum essential me-
dium (MEM) (Eagle) containing Non-
essential amino acids at the same condition 
mentioned above with 5% CO2. The cell 
lines were passaged regularly at 70% con-
fluency. 
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Assessment of cytotoxicity - XTT assay 
Cytotoxicity of the extracts was deter-
mined by XTT-formazan dye formation as-
say (Weislow et al., 1989). MDA-MB-231 
and WRL-68 cells (200 µl, 1 x 104 
cells/well and 6 x 103 cells/well respective-
ly) were seeded in a 96-well plate with their 
respective culture medium and incubated at 
37 °C for 24 h with/without 5% CO2 sup-
ply. After 24 h, the control wells were re-
plenished with fresh medium and the test 
wells were added with medium containing 
25, 50, 100 and 200 µg/ml of the extract. 
The plate was re-incubated for 24 h with 
the same conditions. After incubation peri-
od, each well was replenished with 200 µl 
of fresh medium and 50 µl of XTT (0.6 
mg/ml containing 25 µM PMS). The plate 
was incubated for further 4 h in the same 
conditions after which the absorbance was 
measured at 450 nm (with a 630 nm refer-
ence filter) in a Dynex Opsys MRTM Mi-
croplate Reader (Dynex Technologies, VA, 
USA). Percentage cytotoxicity was calcu-
lated by the following formula:  
% Cytotoxicity = [(Ac-At) / Ac] X 100  
Ac is the mean absorbance of the con-
trol wells and At is the mean absorbance of 
test wells with a particular extract dosage. 
 
Cellular DNA fragmentation ELISA for 
apoptosis 
Apoptosis was determined by a photo-
metric enzyme-linked immunosorbent assay 
(ELISA) kit, in which, Bromodeoxyuridine 
(BrdU) labelled apoptotic DNA fragments 
in cytosolic extracts of culture supernatants 
was detected.The experiment was per-
formed as per the supplier’s instructions. 
Cells (MDA-MB-231 and MCF-7) were la-
beled with 10 µM BrdU at 1 x 105 cells/ml 
density. 1 x 104 BrdU-labeled cells in 
100 µl medium were treated with varying 
concentrations (12.5, 25, 50, 100 and 
200 µg/ml) of the extracts for a period of 
4 h. The cells were then lysed and the su-
pernatant containing apoptotic fragments 
were obtained after centrifugation at 
1500 rpm for 10 min and analyzed through 
ELISA. Obtained sample (100 µl) was 
transferred to anti-DNA coated 96-well flat-
bottom microplate and incubated for 90 min 
at 15-25 °C. The plate was washed with 
washing buffer post-incubation and the 
DNA bound to coated microplate was dena-
tured by microwave irradiation (500 W for 
5 min). The wells were then added with 
100 µl anti-BrdU-POD (Peroxidase) conju-
gate and incubated for 90 min.The plate 
was again washed three times with washing 
buffer and the wells were added with 100 µl 
of 3,3′,5,5′-Tetramethylbenzidine (TMB) 
substrate solution. The plate had been shak-
en until colour development was sufficient 
and the absorbance was read at 450 nm af-
ter addition of 25 µl stop solution. 
 
CPP32/Caspase-3 activation assay 
Caspase-3 activation was determined 
using CPP32/Caspase-3 Colorimetric Assay 
Kit (BioVision Incorporated, CA, USA). 
The assay was performed according to the 
manufacturer’s instructions. MDA-MB-231 
and MCF-7 cells (8 x 105 per 12.5 cm2 cul-
ture flasks) were seeded with their respec-
tive growth medium and incubated for 24 h 
at 37 °C with/without 5% CO2. Hydrogen 
Peroxide (H2O2) (Sigma–Aldrich) was used 
as a positive control for activation of caspa-
se-3 (Dougherty et al., 2008; Abdelwahab 
et al., 2011). Confluent cells were added 
with the respective drug medium (0.1 mM 
H2O2, 61.6 μg/ml PHR and 76.1 μg/ml 
PCR) while maintaining an untreated group 
as negative control, and incubated for 4 h 
maintaining the same conditions. After 
treatment incubation, the floating cells were 
collected from the supernatant. Adherent 
cells were trypsinized and added to the re-
spective tubes and centrifuged to acquire 
cell pellet. Tubes were then added with cell 
lysis buffer and incubated on ice for 10 
min. These tubes were again centrifuged at 
1000 x g and the supernatant containing 
cytosolic extracts were transferred to fresh 
tubes. The protein concentrations of the 
samples were determined following Brad-
ford assay. 100 μg of each protein sample, 
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diluted to 50 μl with cell lysis buffer, were 
added in 96 well plates. About 100 μl of 
reaction buffer, containing 10 mM dithio-
threitol (DTT), were added to respective 
wells and followed by the addition of 5 μl 
of 4 mM Asp-Glu-Val-Asp (DEVD)- pNA 
substrate. The plate was incubated at 37 °C 
for 90 min. Post-incubation the plate was 
read at 405 nm in a Dynex Opsys MRTM 
Microplate Reader (Dynex Technologies, 
VA, USA). Percentage caspase-3 activation 
was calculated from untreated cells as a 
control. 
% Caspase-3 activation = [(At-Ac) / Ac] X 100 
‘At’ is the mean absorbance of test 
wells and ‘Ac’ is the mean absorbance of 
the control wells with respective extract 
dosage. 
 
Cell migration inhibition assay 
The assay was performed according to 
the method described by Dimmeler et al. 
(2000) with some modifications. MDA-
MB-231 cells (6 x 105 per well) were cul-
tured on 6-well plates and incubated at 
37 °C for 24 h to form a confluent mono-
layer. In vitro `scratch' wounds were creat-
ed post-incubation by scrapping the mono-
layer with sterile cell scrapper. Wells were 
washed gently with growth medium to re-
move dislodged cells and were again added 
with the fresh medium in control wells and 
medium containing PHR and PCR in treat-
ment wells. The plates were re-incubated at 
37 °C further to observe a decrease in dis-
tance between the wounded edges at every 
4 h intervals (4, 8, 12 and 16 h). Cell migra-
tion from the injured monolayer was quan-
tified by measuring the distance between 
the wound edges before and after injury us-
ing a computer-attached inverted phase 
contrast microscope (Hund Wetzlar, Ger-
many) at five distinct positions (every 
5 mm). Percentage cell migration was cal-
culated by the following formula:  
% Cell migration = [(D0-Dt) / Dc] X 100 
D0 is the mean distance of the scratch 
wound at time 0 h and Dt is the mean dis-
tance of scratch wound after time t (0, 4, 8, 
12 and 16 h) with respective extract treat-
ment. 
 
Characterisation and quantification of 
polyphenol content 
Phytochemical screening 
Semi-quantitative phytochemical scree-
ning was performed to analyse the class of 
compounds present in the crude extracts. 
The method employed to screen for differ-
ent class of chemicals were as described by 
Trease and Evans (1989), and Ayoola et al. 
(2008). 
Estimation of total phenolic content 
Total phenolic content of the extracts 
were quantified against the standard poly-
phenol, gallic acid, by the method described 
by Rajkumar et al. (2010). Amounts of 20, 
40, 60, 80 and 100 µg extracts were made 
up to 0.5 ml with distilled water in separate 
tubes. An amount of 2.5 ml Folin–
Ciocalteau reagent (1:10 dilution) and 2 ml 
of sodium carbonate (7.5% w/v) were add-
ed to the tubes and incubated at 45 °C for 
15 min. Absorbance was then read at 765 
nm. Results were expressed in gallic acid 
equivalence (GAE) in micrograms.  
Identification of phenolic compounds 
through HPLC 
Analysis was performed using a Waters 
2487 HPLC system consisting of a dual λ 
detector and a Waters 1525 binary pump, 
and equipped with a Waters Symmetry® 
C18 column (5 mm, 4.6 x 150 mm) with 
Waters SentryTM universal guard column (5 
mm, 4.6 x 20 mm) (Waters Corporation, 
Milford, MA, USA). Phenolic compounds 
in PHR and PCR extracts of R. emodi were 
analyzed using the previously reported li-
brary of phenolic standards (Sakakibara et 
al., 2003) as a reference. Gradient elution 
was performed at 35 °C with solution A 
(50 mM sodium phosphate (pH 3.3) and 
10% methanol) and solution B (70% meth-
anol) in the following gradient elution pro-
gram: 
 
 
EXCLI Journal 2013;12:462-478 – ISSN 1611-2156 
Received: May 03, 2013, accepted: May 06, 2013, published: June 04, 2013 
 
 
467 
0 - 15 min: 100% of solution A;  
15 - 45 min: 70% of solution A;  
45 – 65 min: 65% of solution A;  
65 – 70 min: 60% of solution A;  
70 - 95 min: 50% of solution A;  
95 – 100 min: 0% of solution A. 
Flow rate was 1 ml/min and injection 
volume was 20 µl. Detection was monitored 
at diverse wavelengths (around λmax) for 
various phenolic compounds, i.e. 250 nm 
for benzoic acids, isoflavones and most an-
thraquinones; 280 nm for some flavones, 
flavanones, catechins, theaflavins and some 
anthraquinones; 320 nm for cinnamic acids, 
most flavones and chalcones; 370 nm for 
flavonols; 510 nm for anthocyanins. 
 
GC-MS analysis for volatile compounds 
Instrument specifications 
The analysis was performed using 
Thermo GC – Trace Ultra ver 5.0 coupled 
with Thermo MS DSQ II, fixed with a DB 
5 - MS Capillary Standard column (30 m, 
i.d.: 0.25 mm, and film thickness: 0.25 μm).  
Analytical conditions 
Helium was used as a carrier gas (flow-
1.0 ml/min). Injector temperature was 
260 °C and oven temperature gradually 
raised from 80 °C to 260 °C (5 °C/min). 
One μl of sample was injected through in-
jection port and the individual compounds 
were identified based on their retention 
times and standard matching spectral peaks 
available in Wiley mass spectral library. 
 
Statistical analysis 
All analyses were carried out in tripli-
cates. For each assay, data were presented 
as mean ± SD from three independent ex-
periments (n = 3). Statistical analyses were 
performed by one-way ANOVA and signif-
icant differences between groups were de-
termined at P < 0.05. To evaluate relation-
ships between experimental parameters, 
results were analyzed for correlation and 
tested for significance by Student’s t-test 
(P < 0.05). MATLAB ver. 7.0 (Natick, MA, 
USA), GraphPad Prism 5.0 (San Diego, 
CA, USA) and Microsoft Excel 2007 (Ro-
selle, IL, USA) were used for the statistical 
and graphical evaluations. 
 
RESULTS 
Yield of extracts 
Fifty grams of rhizome powder yielded 
0.67 g (percentage extract yield: 1.34 % of 
dry weight) of crude hot petroleum ether 
extract (PHR) and 0.27 g (percentage ex-
tract yield: 0.54 % of dry weight) of crude 
cold petroleum ether extract (PCR). 
 
Antioxidant potentials of the extracts 
Reducing power estimation 
The reducing power of a compound de-
pends on the ability of it to donate an elec-
tron to break the free radical chain (Duh, 
1998). PHR and PCR were able to reduce 
Fe+3 to Fe+2 as indicated by formation of 
Perl’s Prussian blue. The increase in ab-
sorbance corresponds to concentration de-
pendent increase in reducing power of the 
extracts, PHR and PCR, with butylated hy-
droxytoluene (BHT) as a standard (Figure 
1). 
DPPH● scavenging activity 
Both PHR and PCR exhibited a steady 
increase in DPPH● scavenging activity, in 
which the latter was significantly better in 
DPPH● scavenging. Results were illustrated 
as % radical scavenging with equivalence 
to ascorbic acid in micrograms (AAE) 
(Figure 2). 
 
Cell annihilation capability 
Cytotoxicity of the extracts was depict-
ed by colorimetric measurement of XTT-
formazan dye formation through succinate 
dehydrogenase of living cells (Weislow et 
al., 1989). PHR and PCR showcased an in-
crease in % cytotoxicity across the ascend-
ing concentration range in both MDA-MB-
231 and WRL-68 cells (Figure 3). 
 
Apoptosis inductivity 
The ability of extracts to induce apoptosis 
in cancer cells was analysed by quantifying 
EXCLI Journal 2013;12:462-478 – ISSN 1611-2156 
Received: May 03, 2013, accepted: May 06, 2013, published: June 04, 2013 
 
 
468 
the amount of apoptotic BrdU labeled-DNA 
fragments released in the cytoplasm of 
treated cells. Both the extracts entrenched a 
dose dependent increase in apoptotic frag-
ments in both MDA-MB-231 and MCF-7 
cells respectively (Figure 4).  
 
Caspase-3 activation 
Extracts were investigated to check the 
involvement of caspase-3 in its apoptosis 
inductivity. PHR and PCR in their IC50 
range (61.6 μg/ml and 76.1 μg/ml respec-
tively) have demonstrated an evident acti-
vation of caspase-3 in MDA-MB-231 cells 
as compared to that of positive control (0.1 
mM H2O2) (Figure 5). While the drugs 
H2O2, PHR and PCR did not show signifi-
cant caspase-3 activation in MCF-7 cells. 
 
 
 
 
Figure 1: Reducing power of PHR and PCR 
with BHT as standard. Data points are mean 
values ± SD (n = 3, P < 0.05). 
Cell migration inhibition 
PHR and PCR were tested for its ability 
to inhibit the migration of metastatic breast 
cancer cells to prove a characteristic of an 
anti-metastatic agent. MDA-MB-231 cell 
migration, in control wells have gradually 
increased from 0th h to 4th, 8th, 12th and 
16th h by protrusion of cells into the open 
space from edges of scratch wound, to at-
tain a complete confluency at 16th h. Cells 
with addition of PHR (61.6 μg/ml) and PCR 
(76.1 μg/ml) displayed minimal migration 
with some morphological changes till 
16th h, after which no further migration was 
observed (Figure 6(A)). Percentage cell mi-
gration was portrayed in Figure 6(B) show-
ing significant (P < 0.05) difference be-
tween the control and treated groups in its 
migration. 
 
Figure 2: Comparison of DPPH● scavenging 
ability of PHR and PCR expressed in AAE. Da-
ta expressed as % radical scavenging (mean ± 
SD, n = 3, P < 0.05). 
 
 
Figure 3: % Cytotoxicity of PHR and PCR on MDA-MB-231 and WRL-68 cell lines expressed as 
mean ± SD (n = 3). Asterisk (*) indicates a significantly (P < 0.05) lesser cytotoxicity in WRL-68 cells 
compared to MDA-MB-231 cells. 
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Figure 4: Induction of apoptosis corresponding 
to measure of apoptotic DNA fragments in 
MDA-MB-231 and MCF-7 cells by PHR and 
PCR treatment, expressed as OD ± SD (n = 3). 
 
 
Figure 5: % Caspase-3 activation in MDA-MB-
231 cells by 0.1 mM H2O2, 61.6 μg/ml PHR and 
76.1 μg/ml PCR. Data expressed as mean ± SD 
(n = 3).  
 
 
Figure 6: (A) Observation of MDA-MB-231 cells migration, from edges of the scratch wound after  
0, 4, 8, 12 and 16 h in control well (a, b, c, d, e), PHR treated well (f, g, h, i, j) and PCR treated well (k, 
l, m, n, o) respectively (n = 3). (B) Calculated % cell migration of MDA-MB-231 cells, portraying de-
creased migration in PHR and PCR treated cells compared to control cells. Data presented as mean ± 
SD (n = 3). Asterisk (*) indicates significant (P < 0.05) difference from the respective control groups. 
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Quantification and characterisation of 
polyphenol content 
Phytochemical screening 
Screening of the extracts revealed the 
presence of various groups of chemical 
compounds. The hot extracts were found to 
possess additional number of chemical 
groups when compared to cold extracts 
(Table 1).  
Total phenolic content of the extracts 
Results were signified in GAE (in mi-
crograms) as depicted in Table 2. PHR was 
noted to harbor high concentration of phe-
nolics when compared to PCR. The total 
phenolic contents were positively correlated 
(at P < 0.05) to that of the antioxidant effi-
cacies of the extracts conforming that the 
soundness of antioxidant activity was due 
to the presence of polyphenol in the extracts 
(Table 3). 
HPLC analysis 
It is tricky to characterize each and eve-
ry compound in the crude extracts due to 
diversity and complexity of natural phenol-
ic compounds (Surveswaran et al., 2007). 
Accordingly, varied polyphenolic classes 
were identified in PHR and PCR, using the 
reported library of polyphenolic standards 
with analytical characteristics such as λmax, 
retention time, determining λ, slope and 
limit calibration (Sakakibara et al., 2003). 
Phenolics identified were portrayed in the 
Table 4. Both the extracts were also found 
to contain few unknown compounds as ap-
parent from the HPLC chromatograms, 
whose isolation and identification is in pro-
spect. 
Table 1: Semi-quantitative identification of con-
stituents from R. emodi extracts (n = 3). 
Components PHR PCR 
Saponins - - 
Flavonoids ++ ++ 
Terpenoids ++ ++ 
Reducing Sugar ++ + 
Cardiac Glycosides ++ ++ 
Tannins + - 
Anthraquinones ++ - 
Steroids ++ ++ 
Phlobatannins - + 
Oils ++ ++ 
+ = mildly present 
++ = strongly present 
- = absent 
 
 
Table 2: Total phenolic content of R. emodi 
extracts given in mean ± SD (n = 3, P < 0.05). 
GAE of the extracts is expressed in mi-
crograms. 
Amount of 
extracts (µg) 
*GAE ± SD (in µg) 
PHR PCR 
20 7.06 ± 0.12 6.6 ± 0.01 
40 7.46 ± 0.1 7.03 ± 0.14 
60 7.87 ± 0.07 7.36 ± 0.01 
80 8.43 ± 0.05 7.9 ± 0.16 
100 9.01 ± 0.1 8.23 ± 0.05 
*GAE ±SD at 95 % confidence interval. 
 
 
 
Table 3: Correlations between experimental results (of total phenolic estimation, reducing power, 
DPPH) tested for significance. R2 denotes coefficient of determination. 
Extracts Correlations R2 
PHR Total phenolics and DPPH
● scavenging 
Total phenolics and reducing power 
DPPH and reducing power 
0.889* 
0.963** 
0.965** 
PCR Total phenolics and DPPH
● scavenging 
Total phenolics and reducing power 
DPPH and reducing power 
0.815* 
0.904* 
Not significant 
 **Correlation is significant at the 0.01 level 
 *Correlation is significant at the 0.05 level 
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Table 4: Polyphenols identified in PHR and PCR employing HPLC analysis (n = 3) 
Polyphenols λa(nm) EtR
b (min) 
RtRc (min) 
PHR PCR 
Flavones     
1. 7,4’-dihydroxyflavone 320 - 74.924 75.7 
2. Luteolin-4’-O-glucoside 320 - 55.869 54.9 
3. Diosmetin-7-O-rhamnoside (diosmin) 320 62.265 - 61.4 
4. Sinensetin 320 - 85.523 86.3 
Flavonols     
5. Flavonol 370 - 92.179 91.5 
6. kaempferol-7-O-neohesperidoside 370 - 53.930 53.2 
Flavanones     
7. Hesperetin 280 79.091 - 79.4 
8. Hesperetin-7-O-rutinoside (hesperidin) 280 44.891 - 45.6 
Isoflavones     
9. Genistein 250 79.068 - 79.8 
10. Glycitein-7-O-glucoside (glycitin) 250 25.867 - 25.6 
Catechins     
11. (-)-Catechin gallate 280 25.965 - 26.1 
12. (-)-Epicatechin gallate 280 23.293 - 22.9 
a Wavelength for determination, b Experimental retention times, c Reference retention times [Sakakibara et al., 2003]. 
 
 
GC-MS analysis 
The GC-MS analysis of the samples 
PHR and PCR had revealed the presence of 
various volatile components. The major 
components along with their previously re-
ported bioactivities were given in Table 5. 
 
DISCUSSION 
Plants were being used as a source of 
chemopreventives since decades. Many 
plant products have been proved to be ef-
fective against carcinogenesis in the forms 
of dietary supplements, herbal formula-
tions, concoctions or pure phytochemicals 
which act synergistically to give higher ef-
ficiency with lesser side effects (Desai et 
al., 2008). R. emodi was being used as a 
food source and also to meet medical com-
plications, which later was given with sci-
entific evidence to substantiate the prelimi-
nary activities (Babu et al., 2003; Rajkumar 
et al., 2010; 2011; Kounsar et al., 2011). 
However, these studies have reported activ-
ities without attempting to define the mech-
anism of action or chemically characteris-
ing the derivation of bioactivity. Our study 
reports specific anticancer activities of R. 
emodi by defining a possible mode of ac-
tion along with its chemical components 
identified through HPLC and GC-MS tech-
niques. Petroleum ether extracts of R. 
emodi, both in their hot and cold counter-
parts exhibited significant (P < 0.05) thera-
peutic properties in all the test systems ana-
lysed. 
PHR and PCR have shown markable 
antioxidant activities through DPPH and 
reducing power test systems. The antioxi-
dant property of any agent depends upon its 
ability to quench the free radicals generated 
in the test system through reduction reac-
tion (Duh, 1998). Accordingly, PCR had 
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Table 5: Volatile phytoconstituents identified in PHR and PCR employing GC-MS analysis (n = 3) 
S. 
No. Compounds identified 
Rta 
(min) 
Rela-
tive 
area (%) 
Related activity 
 Compounds identified in PHR 
1. 
4,7-Dimethyl-
(octahydro)indolo[4,3-
fg]quinolin-10-one 
33.71 12.81 Quinoline and quinone derivatives 
were well cited for its anticancer prop-
erties  
(Al-Said et al., 2011). 
2. Quinoline, 2-phenyl- 24.74 2.44 
3. 7-Methoxy-2,3-dihydro-2-phenyl-4-quinolone 26.03 1.52 
4. 
3-(1'-
Phenylpropylcarbonyloxy) 
rhinacanthin-A 
33.23 1.79 Rhinacanthin A is recognized as a cy-totoxin (Wu et al., 1988). 
5. 1-anthraquinonesulfenic acid 35.10 1.28 
Anthraquinone derivatives were re-
ported for anticancer properties includ-
ing apoptosis and anti-metastasis 
(Chang et al., 2012). 
6. Valencene-2 14.28 1.23 
A sesquiterpene, present in citrus 
fruits was well known for its anti-
inflammatory (Khan et al., 2011) and 
selective-cytotoxicity towards cancer 
cells (Compagnone et al., 2010). 
7. (.+-.) 3-endo-Hydroxycineole 15.21 1.01 Cineole derivatives were known for its cytotoxic nature (el Hadri et al., 2010). 
8. 9-Octadecenoic acid (Z)-,  methyl ester 28.83 0.75 Both were indubitably reported for its antioxidant activities (Kumar et al., 
2010; Roy et al., 2011). 9. Hexadecanoic acid,  methyl ester 25.23 0.57 
 Compounds identified in PCR 
10. 5-Oxo-isolongifolene 13.45 14.47 
Isolongifolene was reported as cyto-
toxic and apoptotic (Lakshmi et al., 
2008). 
11. (+-)-(5S,9S)-5,9-Dimethylpentadecane 26.76 3.95 
Pentadecane, a basic structural moiety 
of Taxol, a well known anticancer drug 
(Baikar and Malpathak, 2010). 
12. pentadecanoic acid, 14-methyl-,methyl ester 20.97 2.28 
Pentadecanoic acid moiety was re-
ported as an antioxidant (Dr. Duke's 
Phytochemical and Ethnobotanical 
Databases, 1998). 
13. 
(4a'R,6'S,8a'R)-(-)-5',5',8a'-
Trimethyloctahydrospiro[1,3-
dioxolane-2,2'-(1'H)-
naphthalen]-6'-ol 
12.84 1.86 Naphthalene derivatives were ac-counted to possess cytotoxicity and 
antioxidant capacity (Flueraru et al., 
2005). 14. 2-Chloro-2-methyl-1-oxa-2-sila-1,2-dihydronaphthalene 16.69 1.02 
15. Ethyl 1,6-dihydro-5-methyl-6-oxo-2-pyridinecarboxylate 33.38 1.26 
Metal adducts of pyridinecarboxylate 
was known to exhibit high antioxidant 
activities (Corona-Bustamante et al., 
2010). 
16. Tetracosane 32.77 1.85  
Well reported antioxidant (Al-Reza et 
al., 2010). 
 
Apart from these, both the extracts were also found to contain few terpenoids and fatty ac-
ids, where high concentrations of certain terpenoids and fatty acids were known to exhibit 
antioxidant activity (Assimopoulou et al., 2005), and cytotoxicity via apoptosis or necrosis 
(Andrade et al., 2005) respectively. 
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exhibited significantly better free radical 
scavenging when compared to PHR in both 
the antioxidant assays (Figure 1 and Fig-
ure 2). The cytotoxicity of the extracts had 
imparted a contrasting result, where PHR 
was more potent than PCR in its cell anni-
hilation capacity. The 50 and 100 µg/ml 
doses of PCR and 100 µg/ml of PHR have 
exhibited significantly (P < 0.05) higher 
cytotoxicity in cancer cells (MDA-MB-
231) when compared to non-tumoral cells 
(WRL-68) (Figure 3), the property which 
can be used to specifically target cells by 
imparting lesser side effects to normal cells 
in the body.  
The drugs with the ability to extermi-
nate cancer cells are efficient in chemother-
apy of cancer (Mooney, 2005) but still to 
study the mechanism behind the toxicity, 
these extracts were tested for its ability to 
induce apoptosis. Apoptotic induction is 
considered as a specific therapeutic ap-
proach towards cancer chemotherapy, since 
cancer cells lack apoptosis due to dysfunc-
tion of the cell cycle regulation along with 
either an overproliferation of cells and/or 
decreased removal of cells (Elmore, 2007). 
PHR and PCR have shown evident apopto-
sis induction in both the cell lines tested 
(MDA-MB-231 and MCF-7) (Figure 4). 
Apoptosis induction ability of the extracts 
was not studied in WRL-68 cells, as these 
cells were used in cytotoxicity testing; only 
to prove the cancer-cell-specificity of the 
extracts. However, since the study deals 
with anti-breast cancer potential of the ex-
tracts, MCF-7 cells were included in rest of 
the studies. These extracts were found to be 
efficient against MDA-MB-231 cells in 
comparison with MCF-7, where the latter 
appeared to be more resistant to apoptosis 
(Calcabrini et al., 2006; Zhong et al., 2009). 
The exact mechanism behind the activity is 
not known, yet the extracts were consoling-
ly specific to induce apoptosis in estrogen 
receptor (ER)-negative cell system when 
compared to its ER-positive counterpart. 
The extracts were tested for its ability to 
activate caspase-3 in MDA-MB-231 and 
MCF-7 cells. Both PHR and PCR have re-
sulted to significantly activate caspase-3 in 
MDA-MB-231 cells (Figure 5) but not in 
MCF-7 cells.As caspase-3 was naturally 
absent in wild MCF-7 cells due to a dele-
tion in the 47 base-pair region in CASP-3 
gene (Janicke, 2009), the extracts would 
have induced apoptosis in MDA-MB-231 
through caspase-3 activation. This result 
was found concomitant to that of previous 
report (Mandlekar et al., 2000). 
The extracts were also tested to inhibit 
cancer cell migration, which is an attribute 
of metastasis. Consequently, both extracts 
inhibited the migration of metastatic breast 
cancer cells (MDA-MB-231; Figure 6A). 
Unlike control group, the PHR and PCR 
treated cells exhibited decreased % cell mi-
gration at regular time intervals observed 
(4, 8, 12 and 16 h; Figure 6B), and unveiled 
some morphological changes with complete 
arrest of cell migration at 16th h. Similar 
results were reported by Yang et al. (2011) 
and Naveen Kumar et al. (2012). In our 
study, PHR was efficient compared to PCR, 
in inhibiting cell migration at every inter-
val. This property of the extracts concedes 
that PHR and PCR could be considered as a 
source to derive active therapeutic compo-
nents to be used in treating advanced ma-
lignancies of breast cancer. 
Both the extracts were further character-
ised to reveal the phytochemical constitu-
ents. For that reason, the extracts were 
screened semi-quantitatively which di-
vulged the presence of various chemical 
groups. The assessed total phenolic content 
of the extracts have also showed a strong 
positive correlation with antioxidant poten-
tials of the extracts. Similar correlations 
have been previously reported by Guha et 
al. (2010). Consequent to this, the extracts 
were analysed through HPLC to uncover 
the major polyphenols present. PHR and 
PCR were found to contain 12 polyphenols 
collectively (Table 4). The high toxicity of 
PHR is thus justified by the presence of 
catechins (Guha et al., 2010) and the high 
antioxidant activity of PCR is defensible by 
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flavones and flavonols present in it 
(Ramamoorthy and Bono, 2007). Except 
flavonol, other compounds are reported for 
the first time in R. emodi. 
Furthermore, the GC-MS analysis of 
PHR and PCR has revealed the presence of 
diverse volatile components holding high 
therapeutic values, hitherto unreported in R. 
emodi. PHR was found to majorly contain  
 4,7-Dimethyl-
(octahydro)indolo[4,3-fg]quinolin-
10-one (12.81 %) followed by  
 Quinoline, 2-phenyl- (2.44 %), 7-
Methoxy-2,3-dihydro-2-phenyl-4-
quinolone (1.52 %),  
 3-(1'-Phenylpropylcarbonyloxy) 
rhinacanthin-A (1.79 %),  
 1-Anthraquinonesulfenic acid 
(1.28 %), Valencene-2 (1.23 %),  
 (.+-.) 3-endo-Hydroxycineole 
(1.01 %),  
 9-Octadecenoic acid (Z)-, methyl 
ester (0.75 %) and  
 Hexadecanoic acid, methyl ester 
(0.57 %),  
whereas, PCR was found to be rich in  
 5-Oxo-isolongifolene (14.47 %),  
 (+-)-(5S,9S)-5,9-
Dimethylpentadecane (3.95 %),  
 Pentadecanoic acid, 14-methyl-, me-
thyl ester (2.28 %),  
 (4a'R,6'S,8a'R)-(-)-5',5',8a'-
Trimethyloctahydrospiro[1,3-
dioxolane-2,2'-(1'H)-naphthalen]-6'-
ol (1.86 %),  
 2-Chloro-2-methyl-1-oxa-2-sila-1,2-
dihydronaphthalene (1.02 %),  
 Ethyl 1,6-dihydro-5-methyl-6-oxo-
2-pyridinecarboxylate (1.26 %) and  
 Tetracosane (1.85 %).  
These compounds might have played a 
role in diverse anticancer activities show-
cased by PHR and PCR, where such justifi-
cations were also made by Patil et al. 
(2009). As mentioned in Table 5, the com-
pounds identified through GC-MS, directly 
or its derivatives/analogues hold therapeutic 
potentials related to the activities of extracts 
explicated in this study. 
These results, together suggests that the 
R. emodi extracts exhibits cancer-cell-
specific cytotoxicity in ER-negative breast 
cancer cells, through apoptotic induction 
mediated by caspase-3 activation along 
with evident cell migration inhibition po-
tential, and the active principles which have 
been identified by HPLC and GC-MS anal-
yses were possibly responsible for their 
mode of action. 
Resultantly, R. emodi petroleum ether 
extracts accommodate various biological 
properties which exemplify significant an-
tioxidant property, cancer-specific cytotox-
icity, ER-negative cell selective-apoptosis 
inductivity, potent caspase-3 activation and 
evident cell migration inhibition potential. 
Further, the extracts were also found to be 
rich in polyphenols, terpenes, and fatty ac-
ids thus endorsing the reason for its diverse 
therapeutic potentials. These extracts could 
persuasively serve as a source harbouring 
specific therapeutic compounds to treat 
breast cancer in its higher malignancy, and 
thus necessitates its use in dietary-based 
anti-breast cancer therapies.  
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